08 May 2024 - the European Medicines Agency (EMA) announced the withdrawal of the authorisation for AstraZeneca's Vaxzevria at the request of the marketing authorisation holder. The EMA had initially approved AstraZeneca's COVID-19 vaccine in January 2021. However, concerns about its safety arose when several countries suspended its use due to blood clots in vaccinated individuals.